Caigang Xu

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Clinicopathological characteristics and therapeutic outcomes of Kimura disease: A real-world study.

Clinicopathological characteristics and therapeutic outcomes of Kimura disease: A real-world study.

Journal: British journal of haematology

Published: February 09, 2026

Pharmacologic modulation of the SAT1-N1-acetylspermidine axis is associated with enhanced chemotherapy cytotoxicity in T-LBL/ALL cells.

Pharmacologic modulation of the SAT1-N1-acetylspermidine axis is associated with enhanced chemotherapy cytotoxicity in T-LBL/ALL cells.

Journal: Biochemical pharmacology

Published: January 18, 2026

Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.

Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.

Journal: Frontiers in oncology

Published: July 07, 2025

Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study.

Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study.

Journal: Scientific reports

Published: July 02, 2025

The efficacy and survival impact of chidamide on angioimmunoblastic T-cell lymphoma based on Epstein-Barr virus stratification in the real world: A multicenter study.

The efficacy and survival impact of chidamide on angioimmunoblastic T-cell lymphoma based on Epstein-Barr virus stratification in the real world: A multicenter study.

Journal: International journal of cancer

Published: June 16, 2025

Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database.

Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database.

Journal: PloS one

Published: January 24, 2025

Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review.

Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review.

Journal: Frontiers in oncology

Published: August 15, 2024

Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.

Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.

Journal: BMC cancer

Published: June 28, 2024

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm.

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm.

Journal: Frontiers in pharmacology

Published: May 20, 2024

Ferroptosis-related prognostic model of mantle cell lymphoma.

Ferroptosis-related prognostic model of mantle cell lymphoma.

Journal: Open medicine (Warsaw, Poland)

Published: March 05, 2024

Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.

Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.

Journal: British journal of haematology

Published: June 15, 2023

Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment.

Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment.

Journal: Frontiers in pharmacology

Published: October 25, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026